Stockreport

ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]

ALX Oncology Holdings Inc.  (ALXO) 
PDF ALX2004 remains on track following strong 2025 execution; company anticipates multiple meaningful data sets and milestones in the coming 12 to 18 months - - Evorpacept [Read more]